PHARMACOLOGICAL CRITERIA FOR THE TESTING OF ANTI-CANCER DRUGS

被引:0
|
作者
DRUCKREY, H
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:382 / 392
页数:11
相关论文
共 50 条
  • [21] METABOLISM OF ANTI-CANCER DRUGS
    CONNORS, TA
    [J]. BIOCHIMIE, 1978, 60 (09) : 1070 - 1070
  • [22] Anti-cancer drugs for thyroid cancer
    Tahara, Makoto
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 63 - 63
  • [23] Regulatory Approaches to Nonclinical Reproductive Toxicity Testing of Anti-Cancer Drugs
    Barrow, Paul
    Schmitt, Georg
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (09) : 1171 - 1183
  • [24] FORMULATION OF INVESTIGATIONAL ANTI-CANCER DRUGS
    REPTA, AJ
    [J]. PHARMACY INTERNATIONAL, 1981, 2 (07): : ABS2 - ABS2
  • [25] EFFECT OF ANTI-CANCER DRUGS ON COMPLEMENT
    MCKENZIE, D
    CLOSKY, J
    HETRICK, D
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1970, 11 : 54 - &
  • [26] MCAB TARGETING ANTI-CANCER DRUGS
    BALDWIN, RW
    [J]. BRITISH JOURNAL OF CANCER, 1984, 50 (04) : 561 - 562
  • [27] Are isothiocyanates potential anti-cancer drugs?
    Wu, Xiang
    Zhou, Qing-hua
    Xu, Ke
    [J]. ACTA PHARMACOLOGICA SINICA, 2009, 30 (05) : 501 - 512
  • [28] PREDICTION OF RESPONSE TO ANTI-CANCER DRUGS
    FAVRE, R
    PIGNON, T
    MAROTIA, L
    SEITZ, JF
    DELPERO, JR
    GUERINEL, G
    CARCASSONNE, Y
    [J]. PRESSE MEDICALE, 1983, 12 (45): : 2875 - 2879
  • [29] THE RISING COST OF ANTI-CANCER DRUGS
    Karikios, D. J.
    Schofield, D.
    Salkeld, G.
    Mann, K. P.
    Trotman, J.
    Stockler, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : E35 - E35
  • [30] Anthelmintics as Potential Anti-Cancer Drugs?
    Heo, Dae Seog
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (06)